The receptor NLRP3 is a transcriptional regulator of TH2 differentiation

[1]  M. Bix,et al.  An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis. , 2015, The Journal of clinical investigation.

[2]  B. Ryffel,et al.  The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells , 2014, Nature Immunology.

[3]  B. N. Devaiah,et al.  CIITA and Its Dual Roles in MHC Gene Transcription , 2013, Front. Immunol..

[4]  Xin Geng,et al.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection , 2013, Nature.

[5]  R. Lamaita,et al.  Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer , 2013, Reproductive Sciences.

[6]  D. Shima,et al.  A2E Induces IL-1ß Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome , 2013, PloS one.

[7]  S. Akira,et al.  Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome , 2013, Nature Immunology.

[8]  H. Duff,et al.  Inflammasome-Independent NLRP3 Augments TGF-β Signaling in Kidney Epithelium , 2013, The Journal of Immunology.

[9]  Bernhard Mlecnik,et al.  CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data , 2013, Bioinform..

[10]  B. Fingleton,et al.  Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. , 2012, Cancer research.

[11]  Wilfrid Boireau,et al.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth , 2012, Nature Medicine.

[12]  Emmanuel Barillot,et al.  Nebula - a web-server for advanced ChIP-seq data analysis , 2012, Bioinform..

[13]  Daniel J. Blankenberg,et al.  Using Galaxy to Perform Large‐Scale Interactive Data Analyses , 2012, Current protocols in bioinformatics.

[14]  Alexandra F. Elli,et al.  Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation , 2012, Proceedings of the National Academy of Sciences.

[15]  Matthew J. Craig,et al.  IL‐4 induces proliferation in prostate cancer PC3 cells under nutrient‐depletion stress through the activation of the JNK‐pathway and survivin up‐regulation , 2012, Journal of cellular biochemistry.

[16]  X. Hua,et al.  Analysis of NLRP3 in the Development of Allergic Airway Disease in Mice , 2012, The Journal of Immunology.

[17]  P. Serafini,et al.  Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression. , 2012, Cancer research.

[18]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[19]  J. Tschopp,et al.  NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant , 2011, Allergy.

[20]  H. Hammad,et al.  An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. , 2011, Immunity.

[21]  J. Joyce,et al.  Alternative activation of tumor-associated macrophages by IL-4 , 2010, Cell cycle.

[22]  H. Schild,et al.  Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. , 2010, Immunity.

[23]  B. Fingleton,et al.  Epithelial interleukin-4 receptor expression promotes colon tumor growth. , 2010, Carcinogenesis.

[24]  J. Tschopp,et al.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors , 2009, Nature Medicine.

[25]  A. Rudensky,et al.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses , 2009, Nature.

[26]  W. Miyazaki,et al.  Liquid chemiluminescent DNA pull-down assay to measure nuclear receptor-DNA binding in solution. , 2008, BioTechniques.

[27]  H. Hammad,et al.  Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome , 2008, The Journal of Immunology.

[28]  Richard A. Flavell,et al.  Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants , 2008, Nature.

[29]  Rakesh K. Kumar,et al.  The "classical" ovalbumin challenge model of asthma in mice. , 2008, Current drug targets.

[30]  W. Koltun,et al.  IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells. , 2008, Cytokine.

[31]  T. Mak,et al.  Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[33]  L. Glimcher,et al.  Interferon Regulatory Factor 4 (IRF4) Interacts with NFATc2 to Modulate Interleukin 4 Gene Expression , 2002, The Journal of experimental medicine.

[34]  J. Ting,et al.  Mechanisms of Nuclear Import and Export That Control the Subcellular Localization of Class II Transactivator1 , 2001, The Journal of Immunology.

[35]  G. Wise,et al.  Cytokine variations in patients with hormone treated prostate cancer. , 2000, The Journal of urology.

[36]  S. Gerondakis,et al.  Rel Induces Interferon Regulatory Factor 4 (IRF-4) Expression in Lymphocytes , 2000, The Journal of experimental medicine.

[37]  W. Schultze‐Seemann,et al.  Th1 and Th2 Cytokine Response Patterns in Leukocyte Cultures of Patients with Urinary Bladder, Renal Cell and Prostate Carcinomas , 1998, Tumor Biology.

[38]  Makiko Kobayashi,et al.  A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. , 1998, Journal of immunology.

[39]  T. Mak,et al.  Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-p25. , 1996, Genomics.

[40]  A. Brass,et al.  Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. , 1996, Genes & development.

[41]  S. Dyhrman,et al.  In situ cytokine production by breast cancer tumor-infiltrating lymphocytes , 1996, Annals of Surgical Oncology.

[42]  S. McKnight,et al.  Identification and purification of human Stat proteins activated in response to interleukin-2. , 1995, Immunity.

[43]  R. Coffman,et al.  Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivo , 1993, European journal of immunology.

[44]  W. Paul,et al.  Molecular dissection of the mouse interleukin-4 promoter. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Warner.  Responding to aggression. , 1992, Nursing times.

[46]  V. Feron,et al.  Upper respiratory tract tumors in Cpb:WU (Wistar random) rats. , 1990, Environmental health perspectives.

[47]  G. Farrell.  Responding to aggression; the role of significant others for student psychiatric nurses, an ethnographic study. , 1989, Nurse education today.

[48]  W. Paul,et al.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2 , 1982, The Journal of experimental medicine.

[49]  E. Latz,et al.  New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. , 2014, The American journal of pathology.

[50]  T. Matsuyama,et al.  Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. , 2003, International immunology.